Wij zijn onze website aan het vernieuwen.

Ontdekt u nog een pagina die niet klopt of hebt u een goede suggestie, laat het ons dan weten via webmedia@umcutrecht.nl.

Deze website maakt gebruik van cookies

Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Lees meer over het cookiebeleid.

Preventing antimicrobial resistance

Focus

The focus of research activities in this theme are:

  • to quantify and understand the relationship between antibiotic use and AMR in and in-between humans and animals;
  • to determine the population structure and evolution of multidrug-resistant opportunistic pathogens in humans and animals;
  • to develop and scientifically evaluate infection prevention measures in hospitalized patients and community-dwelling subjects;
  • to optimize diagnosis and treatment of infections, in order to minimize unnecessary antibiotic use in hospitals and in primary care;
  • to better understand infection pathogenesis among those patients experiencing the highest burden of antibiotic selective pressure (for example, intensive care unit patients);
  • to develop tools and to quantify the burden of AMR;
  • to develop an international clinical research infrastructure to increase efficiency of clinical evaluation of new antimicrobial therapies.
To top